Life-Years Saved After Pediatric Liver Transplantation.
SUNY Upstate Medical University, Syracuse, NY.
Meeting: 2016 American Transplant Congress
Abstract number: B178
Keywords: Liver transplantation, Pediatric
Session Information
Session Name: Poster Session B: Kidney Issue in Liver Transplantation
Session Type: Poster Session
Date: Sunday, June 12, 2016
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Halls C&D
Introduction: Transplantation has provided tremendous progress for pediatric patients with liver failure.We determined the survival benefit for pediatric patients as reported to UNOS.
Methods: In this analysis of UNOS data, we reviewed the records of a total of 14,623 pediatric patients listed for primary liver transplant alone. Children who received a living donor transplant (n=1,478) were excluded from analysis. Of the remaining 13,174 cases, 10,174 children underwent transplant; the remaining 2,690 children were either still waiting or died on the waiting list. We categorized the children according to their diagnosis as: Biliary Atresia (BA) (38%), Cirrhosis (17%), Fulminant Liver Failure (FLF)(15%), Metabolic Disease (MD) (12%), Liver Tumor (LT) (6%) and others (12%).
The primary outcome was patient death. Patient survival on the waitlist and after transplant was computed according to Kaplan from the time of first listing.
Results: Waitlist survival was dependent on underlying disease. 1-yr patient survival (transplanted children were censored) was: for MD 92%; BA 92%; Cirrhosis 91%;FLF 64%; LT 64%; others 53%. 5-year patient survival transplanted children was: for MD 90%; BA 88%; Cirrhosis 88%; FLF 77%; LT 75%; others 80%.
Table 1 shows the total and the average life-years saved. The highest number of total years saved was for chronic diseases (MD, BA), where there was time to find a perfect donor. The total life-years saved for the more acute diagnoses (FLF, LT) are also favorable. However, the average life-years saved were higher for acute than chronic diseases.
Category |
N |
Total Life-Years saved |
Average Life-Years saved |
|
Biliary Atresia |
Waiting list |
4967 |
– |
|
Transplant |
4418 |
1,994 |
0.45 |
|
Cirrhosis |
Waiting list |
2266 |
||
Transplant |
1764 |
1,663 |
0.94 |
|
Fulminant |
Waiting list |
1995 |
– |
|
Transplant |
1577 |
1,878 |
1.19 |
|
Metabolic Disease |
Waiting list |
|
|
|
Transplant |
1415 |
2,015 |
1.14 |
|
Liver Tumors |
Waiting list |
705 |
|
|
Transplant |
617 |
1,837 |
2.98 |
|
Other |
Waiting list |
1612 |
|
|
Transplant |
664 |
1,783 |
2.97 |
Conclusion: The number of life-years saved was dependent on waitlist mortality. It was lower for chronic than for acute diseases. Because the mortality of a liver tx is relatively high, the number of life-years saved is relatively low for pediatric liver tx recipients. The average life-years saved were higher for acute than chronic diseases.
CITATION INFORMATION: Gruessner R, Gruessner A. Life-Years Saved After Pediatric Liver Transplantation. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:
Gruessner R, Gruessner A. Life-Years Saved After Pediatric Liver Transplantation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/life-years-saved-after-pediatric-liver-transplantation/. Accessed November 22, 2024.« Back to 2016 American Transplant Congress